- 全部删除
您的购物车当前为空
Mcl-1 inhibitor20(compound 47)是一种针对Mcl-1的强效抑制剂,显示出对白血病的抗生物活性。它与Mcl-1的BH3结合槽发生作用(Ki=24 nM),有效占据其P1口袋,并与Lys234及Val249残基产生相互作用。此外,Mcl-1 inhibitor20展现出优异的微粒体稳定性、药物代谢动力学属性以及较低的心脏毒性。
Mcl-1 inhibitor20(compound 47)是一种针对Mcl-1的强效抑制剂,显示出对白血病的抗生物活性。它与Mcl-1的BH3结合槽发生作用(Ki=24 nM),有效占据其P1口袋,并与Lys234及Val249残基产生相互作用。此外,Mcl-1 inhibitor20展现出优异的微粒体稳定性、药物代谢动力学属性以及较低的心脏毒性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | Mcl-1 inhibitor20 (compound 47) is an Mcl-1 antagonist with anti-leukemia properties. It binds to the BH3 docking groove of Mcl-1 (Ki=24 nM), occupies the P1 pocket, and interacts with Lys234 and Val249. Mcl-1 inhibitor20 also exhibits good microsomal stability, favorable pharmacokinetic properties, and low cardiotoxicity. |
| 分子量 | 990.62 |
| 分子式 | C55H61ClFN5O7S |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容